Literature DB >> 34782783

Bacteriophages and their potential for treatment of gastrointestinal diseases.

Yi Duan1,2, Ry Young3,4,5, Bernd Schnabl6,7,8.   

Abstract

Although bacteriophages have been overshadowed as therapeutic agents by antibiotics for decades, the emergence of multidrug-resistant bacteria and a better understanding of the role of the gut microbiota in human health and disease have brought them back into focus. In this Perspective, we briefly introduce basic phage biology and summarize recent discoveries about phages in relation to their role in the gut microbiota and gastrointestinal diseases, such as inflammatory bowel disease and chronic liver disease. In addition, we review preclinical studies and clinical trials of phage therapy for enteric disease and explore current challenges and potential future directions.
© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Entities:  

Mesh:

Year:  2021        PMID: 34782783      PMCID: PMC8966578          DOI: 10.1038/s41575-021-00536-z

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  186 in total

1.  Origins of highly mosaic mycobacteriophage genomes.

Authors:  Marisa L Pedulla; Michael E Ford; Jennifer M Houtz; Tharun Karthikeyan; Curtis Wadsworth; John A Lewis; Debbie Jacobs-Sera; Jacob Falbo; Joseph Gross; Nicholas R Pannunzio; William Brucker; Vanaja Kumar; Jayasankar Kandasamy; Lauren Keenan; Svetsoslav Bardarov; Jordan Kriakov; Jeffrey G Lawrence; William R Jacobs; Roger W Hendrix; Graham F Hatfull
Journal:  Cell       Date:  2003-04-18       Impact factor: 41.582

2.  Antibacterial application of engineered bacteriophage nanomedicines: antibody-targeted, chloramphenicol prodrug loaded bacteriophages for inhibiting the growth of Staphylococcus aureus bacteria.

Authors:  Lilach Vaks; Itai Benhar
Journal:  Methods Mol Biol       Date:  2011

3.  Structural and functional insights into the regulation of the lysis-lysogeny decision in viral communities.

Authors:  Chao Dou; Jie Xiong; Yijun Gu; Kun Yin; Jinjing Wang; Yuehong Hu; Dan Zhou; Xianghui Fu; Shiqian Qi; Xiaofeng Zhu; Shaohua Yao; Heng Xu; Chunlai Nie; Zongan Liang; Shengyong Yang; Yuquan Wei; Wei Cheng
Journal:  Nat Microbiol       Date:  2018-10-15       Impact factor: 17.745

Review 4.  You are what you eat: diet, health and the gut microbiota.

Authors:  Niv Zmora; Jotham Suez; Eran Elinav
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-01       Impact factor: 46.802

Review 5.  Bacteriophages of the Human Gut: The "Known Unknown" of the Microbiome.

Authors:  Andrey N Shkoporov; Colin Hill
Journal:  Cell Host Microbe       Date:  2019-02-13       Impact factor: 21.023

6.  Classification and quantification of bacteriophage taxa in human gut metagenomes.

Authors:  Alison S Waller; Takuji Yamada; David M Kristensen; Jens Roat Kultima; Shinichi Sunagawa; Eugene V Koonin; Peer Bork
Journal:  ISME J       Date:  2014-03-13       Impact factor: 10.302

7.  Self-limiting nature of seasonal cholera epidemics: Role of host-mediated amplification of phage.

Authors:  Shah M Faruque; M Johirul Islam; Qazi Shafi Ahmad; A S G Faruque; David A Sack; G Balakrish Nair; John J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-13       Impact factor: 11.205

8.  Gene transfer to myxobacterium by Escherichia coli phage P1.

Authors:  D Kaiser; M Dworkin
Journal:  Science       Date:  1975-02-21       Impact factor: 47.728

9.  T4 phage and its head surface proteins do not stimulate inflammatory mediator production.

Authors:  Paulina Miernikiewicz; Krystyna Dąbrowska; Agnieszka Piotrowicz; Barbara Owczarek; Justyna Wojas-Turek; Jagoda Kicielińska; Joanna Rossowska; Elżbieta Pajtasz-Piasecka; Katarzyna Hodyra; Katarzyna Macegoniuk; Kamila Rzewucka; Agnieszka Kopciuch; Tomasz Majka; Andrey Letarov; Eugene Kulikov; Henryk Maciejewski; Andrzej Górski
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

10.  Reproducible protocols for metagenomic analysis of human faecal phageomes.

Authors:  Andrey N Shkoporov; Feargal J Ryan; Lorraine A Draper; Amanda Forde; Stephen R Stockdale; Karen M Daly; Siobhan A McDonnell; James A Nolan; Thomas D S Sutton; Marion Dalmasso; Angela McCann; R Paul Ross; Colin Hill
Journal:  Microbiome       Date:  2018-04-10       Impact factor: 14.650

View more
  5 in total

1.  A balanced gut microbiota is essential to maintain health in captive sika deer.

Authors:  Yu Wang; Jin Xu; Huan Chen; Jinyan Yu; Xiaomeng Xu; Lin Sun; Xun Xu; Chenyi Yu; Fei Xu; Jinlin Huang; Xin'an Jiao; Yunzeng Zhang
Journal:  Appl Microbiol Biotechnol       Date:  2022-08-04       Impact factor: 5.560

Review 2.  Promises of microbiome-based therapies.

Authors:  Jasmohan S Bajaj; Siew C Ng; Bernd Schnabl
Journal:  J Hepatol       Date:  2022-06       Impact factor: 30.083

Review 3.  Should Bacteriophages Be Classified as Parasites or Predators?

Authors:  Grzegorz Węgrzyn
Journal:  Pol J Microbiol       Date:  2022-02-23

Review 4.  Gut Microbiome in Inflammatory Bowel Disease: Role in Pathogenesis, Dietary Modulation, and Colitis-Associated Colon Cancer.

Authors:  John Gubatan; Theresa Louise Boye; Michelle Temby; Raoul S Sojwal; Derek R Holman; Sidhartha R Sinha; Stephan R Rogalla; Ole Haagen Nielsen
Journal:  Microorganisms       Date:  2022-07-07

5.  Immune Response of an Oral Enterococcus faecalis Phage Cocktail in a Mouse Model of Ethanol-Induced Liver Disease.

Authors:  Beatriz Garcia Mendes; Yi Duan; Bernd Schnabl
Journal:  Viruses       Date:  2022-02-27       Impact factor: 5.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.